Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
Watch
on air now

Create a 3AW account today!

You can now log in once to listen live, watch live, join competitions, enjoy exclusive 3AW content and other benefits.


Joining is free and easy.

You will soon need to register to keep streaming 3AW online. Register an account or skip for now to do it later.

Advertisement
Advertisement
Advertisement

COVAX-19: The Australian vaccine that has already ‘shown it can potentially save lives’

Neil Mitchell
Article image for COVAX-19: The Australian vaccine that has already ‘shown it can potentially save lives’

A leading South Australian vaccine is showing promising signs it “could actually save lives”, and the developers of the vaccine say it could safely be used in human immediately.

The first stage of human trials of the vaccine, known as covax-19, have almost wrapped up, and vaccine developer Professor Nikolai Petrovsky says there’s no reason it can’t be used in Victorian aged care homes now.

“We have something that we believe already has shown it can potentially save lives,” he told Neil Mitchell.

“Obviously, we’re still under the clinical trial phase but there’s no reason those trials couldn’t be extended to nursing homes in Victoria, just as we’re currently doing in South Australia.

“The data suggests it’s highly effective, we just need to finish the clinical trial programs and then seek approval for it.

“There’s no reason it can’t be used before that because it is safe, so you’re not going to lose anything by using it … We’ve used very similar vaccines in thousands of people for influenza.”

Professor Petrovsky says the vaccine has been shown to produce “very strong” antibodies which kill coronavirus in monkeys, ferrets and mice, and has been proven to induce an antibody response in humans.

Press PLAY below for more on the promising vaccine.

Neil Mitchell
Advertisement